Literature DB >> 24833763

ERS/WHO Tuberculosis Consilium assistance with extensively drug-resistant tuberculosis management in a child: case study of compassionate delamanid use.

Susanna Esposito1, Lia D'Ambrosio2, Marina Tadolini3, H Simon Schaaf4, Josè Caminero Luna5, Ben Marais6, Rosella Centis7, Masoud Dara8, Alberto Matteelli9, Francesco Blasi10, Giovanni Battista Migliori11.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24833763     DOI： 10.1183/09031936.00060414

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  29 in total

1.  A new free-cost e-service supporting clinicians to manage their difficult-to-treat TB cases: the ERS-WHO TB consilium.

Authors:  Lia D'Ambrosio; Marina Tadolini; Rosella Centis; Giovanni Battista Migliori
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

2.  The multidrug-resistant tuberculosis threat: old problems and new solutions.

Authors:  Giovanni Sotgiu; Lia D'Ambrosio; Rosella Centis; Ida Mura; Paolo Castiglia; Antonio Spanevello; Giovanni Battista Migliori
Journal:  J Thorac Dis       Date:  2015-09       Impact factor: 2.895

3.  Classification of drugs to treat multidrug-resistant tuberculosis (MDR-TB): evidence and perspectives.

Authors:  Adrian Rendon; Simon Tiberi; Anna Scardigli; Lia D'Ambrosio; Rosella Centis; Jose A Caminero; Giovanni Battista Migliori
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

Review 4.  New agents for the treatment of drug-resistant Mycobacterium tuberculosis.

Authors:  Daniel T Hoagland; Jiuyu Liu; Robin B Lee; Richard E Lee
Journal:  Adv Drug Deliv Rev       Date:  2016-05-02       Impact factor: 15.470

Review 5.  Delamanid and bedaquiline to treat multidrug-resistant and extensively drug-resistant tuberculosis in children: a systematic review.

Authors:  Lia D'Ambrosio; Rosella Centis; Simon Tiberi; Marina Tadolini; Margareth Dalcolmo; Adrian Rendon; Susanna Esposito; Giovanni Battista Migliori
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

6.  Timing is everything for compassionate use of delamanid.

Authors:  Clifton E Barry
Journal:  Nat Med       Date:  2015-03       Impact factor: 53.440

Review 7.  Future target-based drug discovery for tuberculosis?

Authors:  Bavesh Davandra Kana; Petros C Karakousis; Tanya Parish; Thomas Dick
Journal:  Tuberculosis (Edinb)       Date:  2014-12       Impact factor: 3.131

Review 8.  Advances in Drug Discovery and Development for Pediatric Tuberculosis.

Authors:  Daniel Hoagland; Ying Zhao; Richard E Lee
Journal:  Mini Rev Med Chem       Date:  2016       Impact factor: 3.862

9.  Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines.

Authors:  Marco Schito; Giovanni Battista Migliori; Helen A Fletcher; Ruth McNerney; Rosella Centis; Lia D'Ambrosio; Matthew Bates; Gibson Kibiki; Nathan Kapata; Tumena Corrah; Jamshed Bomanji; Cris Vilaplana; Daniel Johnson; Peter Mwaba; Markus Maeurer; Alimuddin Zumla
Journal:  Clin Infect Dis       Date:  2015-10-15       Impact factor: 9.079

10.  Multidisciplinary management of difficult-to-treat drug resistant tuberculosis: a review of cases presented to the national consilium in Uganda.

Authors:  Joseph Baruch Baluku; Richard Katuramu; Joshua Naloka; Enock Kizito; Martin Nabwana; Felix Bongomin
Journal:  BMC Pulm Med       Date:  2021-07-10       Impact factor: 3.317
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.